reported modest impact on the liver with long-term targeting strategies (22, 24), suggesting that acute treatments targeting DPP4 more readily influence mouse lipid metabolism than long-term deletion of DPP4, which may be prone to metabolic adaptation
Side effects such as allergic reactions and irritation at the injection site can occur with both steroids and peptides
Listed effects of GLP-1 include: 1) reduced glucagon secretion from the liver (thereby slowing down the release of glucose, or blood sugar, into the bloodstream during periods of fasting or reduced food intake), 2) increased insulin production, 3) decreased appetite, and 4) decreased intestinal motility (causing food to move slower through the digestive system, thereby further improving blood sugar and reducing appetite)
Conversely, patients who adopt a balanced, whole-foods-based eating pattern with appropriate portion control typically achieve superior results